JMN Financial’s AbbVie ABBV Stock Holding History

JMN Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$490K	Sell	1,948 -257	-12%	-$55.3K	0.38%	70
2026 Q1	$480K	Sell	2,205 -288	-12%	-$63.9K	0.47%	59
2025 Q4	$570K	Buy	+2,493	New	+$568K	0.57%	40

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JMN Financial's ABBV Position: Q2 2026 in Review

JMN Financial reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $55.3K and leaving 1,948 shares worth $490K. The position accounts for 0.38% of the portfolio, ranked #70.

JMN Financial first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $570K in Q4 2025. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

JMN Financial held 1,948 shares of AbbVie worth $490K as of Q2 2026.
JMN Financial sold 257 AbbVie shares in Q2 2026, an estimated $55.3K.
AbbVie made up 0.38% of JMN Financial's portfolio in Q2 2026, its #70 holding.
JMN Financial first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
JMN Financial's AbbVie position peaked at $570K in Q4 2025.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JMN Financial's 13F filing for Q2 2026, filed 10 Aug 2026.